Recent News
Techniques for Determining a Mesothelioma Diagnosis
If you have been exposed to asbestos and are exhibiting symptoms of mesothelioma including: pain in the side of your chest and lower back, shortness of breath, cough, fever, excessive[…]
ONCOS-102 Update: Mesothelioma Patients Responded after Phase II Clinical Trial
Advancement in mesothelioma treatments over the past decade has been relativity stagnant, according to Targovax – a Norwegian immune-cology company dedicated to the study and research of immunotherapy treatments. However,[…]
Safer and Less Intrusive Lung Cancer Test
In order to test for cancer, people have to go through invasive and even risky procedures to remove and biopsy a tumor. With these risky procedures between 75 and 85[…]
Aerosol Chemotherapy – Targeting Peritoneal Mesothelioma Through Pressurized Medicine
Peritoneal mesothelioma is an incredibly rare form of cancer that affects the peritoneum, or abdominal lining. It is not entirely understood how exposure to asbestos causes this type of cancer,[…]
New Surgical Technique Could Be Ideal for Patients with Advanced Pleural Mesothelioma
Pleural mesothelioma is a rare and aggressive cancer that has been notoriously difficult to treat. Caused by asbestos exposure, the latency period between the time of initial exposure and disease[…]
Immunotherapy May Help Extend the Lives of Lung Cancer and Mesothelioma Patients
Immunotherapy is revolutionizing the health care industry by adding extra years of life to people with lung cancer. A few years ago it was rare for patients with an advanced[…]
Immunotherapy Treatment Durvalumab Enters Phase II Clinical Trial
While there is no cure for mesothelioma, those who are able to withstand surgery in general may have a better chance of survival, as the cancer is being physically removed.[…]
Understanding Asbestos Exposure and Mesothelioma
Exposure to asbestos does not always mean that the individual exposed will develop an asbestos-caused disease or cancer. However, there is no safe level of asbestos exposure, and if you[…]
Asbestos Exposure Documentary Makes Debut At International Film Festival
Last weekend at the San Luis Obispo International Film Festival, a 75- minute documentary about asbestos exposure and mesothelioma made its world debut, highlighting the aggressive and often fatal diseases[…]
Biomarker CD47 as a Successful Diagnostic and Treatment Tool
Survival rates for diffuse mesothelioma are notoriously low with the median survival ranging between 12 to 22 months. A contributing factor to treatment being ineffective is that the disease if[…]
Skip to content